Search results
Results From The WOW.Com Content Network
On December 20, 2018, the 2018 United States farm bill was signed into law, legalizing the cultivation of hemp containing less than 0.3% THC at the federal level. An unintended consequence of the bill was that it also legalized at the federal level the production of delta-8-THC, an isomer of THC with similar psychoactive effects. Use of delta-8 ...
In Washington, D.C., cannabis is legal for both medical use and recreational use for possession, personal use, cultivation, transportation and gifting, and for retail sale once a regulatory system is implemented following an affirmative vote by the residents on a 2014 ballot initiative.
On December 17, 2009, Rev. Bryan A. Krumm, CNP, filed a rescheduling petition for Cannabis with the DEA arguing that "because marijuana does not have the abuse potential for placement in Schedule I of the CSA, and because marijuana now has accepted medical use in 13 states, and because the DEA's own Administrative Law Judge has already ...
In fact, Delta-8 is legal in every state below the Mason-Dixon. In Mississippi, there is a bit of a gray area, as the Farm Bill allows hemp, but hemp-derived products are exempt. However, some ...
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
For premium support please call: 800-290-4726 more ways to reach us
Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a type of cannabis. It carries a low amount of hemp (0.3%) and, therefore, is permitted under Chapter 443 of the Texas Health and Safety ...
[28] [29] In August 2023, following a review by the Food and Drug Administration, the Department of Health and Human Services issued a recommendation to the DEA that cannabis be moved to Schedule III. [30] In April 2024, the DEA confirmed its intention to reclassify cannabis as a Schedule III drug, pending review by the Office of Management and ...